Australia markets closed

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
13.70+0.67 (+5.14%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,628,176
3,931,387
3,712,720
3,686,693
2,914,881
Cost of revenue
2,001,427
2,028,721
1,767,998
1,596,122
1,196,265
Gross profit
1,626,749
1,902,666
1,944,723
2,090,571
1,718,616
Operating expenses
Research development
379,553
372,294
263,662
220,955
187,532
Selling general and administrative
416,162
464,961
517,187
526,597
519,423
Total operating expenses
880,276
939,584
912,050
848,998
742,397
Operating income or loss
746,473
963,082
1,032,672
1,241,573
976,219
Interest expense
81,909
81,045
57,847
92,215
57,565
Income before tax
-475,936
-294,759
1,185,369
1,203,754
914,632
Income tax expense
-131,349
-105,312
98,850
139,838
117,977
Income from continuing operations
-344,587
-189,447
1,086,519
1,063,916
796,655
Net income
-344,581
-189,446
1,090,833
1,059,293
806,122
Net income available to common shareholders
-344,581
-189,446
1,090,833
1,059,293
806,122
Basic EPS
0.63
-0.12
0.67
0.67
0.66
Diluted EPS
0.63
-0.12
0.67
0.67
0.66
Basic average shares
1,623,853
1,578,715
1,628,109
1,581,035
1,221,397
Diluted average shares
1,623,853
1,578,715
1,628,109
1,557,784
1,203,167